Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;176(18):3649-3665.
doi: 10.1111/bph.14637. Epub 2019 Apr 23.

Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues

Lars M Ittner  1   2 , Matthias Klugmann  2 , Yazi D Ke  1   2
Affiliations
Review

Adeno-associated virus-based Alzheimer's disease mouse models and potential new therapeutic avenues

Lars M Ittner et al. Br J Pharmacol. 2019 Sep.

Abstract

Alzheimer's disease (AD) is a highly prevalent neurodegenerative condition that presents with cognitive decline. The current understanding of underlying disease mechanisms remains incomplete. Genetically modified mouse models have been instrumental in deciphering pathomechanisms in AD. While these models were typically generated by classical transgenesis and genome editing, the use of adeno-associated viruses (AAVs) to model and investigate AD in mice, as well as to develop novel gene-therapy approaches, is emerging. Here, we reviewed literature that used AAVs to study and model AD and discuss potential gene therapy strategies. LINKED ARTICLES: This article is part of a themed section on Therapeutics for Dementia and Alzheimer's Disease: New Directions for Precision Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.18/issuetoc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Potential of AAV in advancing AD studies and therapies. Combining AAV with either wild‐type (non‐transgenic) or established genetically modified lines (including AD models) offers the opportunity to generate new AD models and interrogate existing AD models to understand underlying disease mechanisms. Furthermore, AAV has been used to interfere with pathological processes in AD mouse models, establishing proof‐of‐concept for potential gene therapies
Figure 2
Figure 2
Different modes of delivering AAV for CNS gene expression in mice. (a) Common methods reported for delivering AAV‐mediated gene expression in neonatal mice include (A) direct stereotaxic brain infusion, (B) spinal cord injections, and (C) intravascular delivery. (b) Techniques most frequently reported for delivering AAV‐mediated gene expression in mature mice include (D) direct stereotaxic brain infusion, (E) spinal cord injections, (F) intravascular, and (G) i.m. delivery. (c) Two commonly used methods for intracerebral delivery of AAV in adult brains are (H) intracerebrovascular injection for widespread gene expression or (I) into distinct brain areas for localized expression. Both techniques require the use of stereotaxic devices for guided injections
See this image and copyright information in PMC

References

    1. Ahmed, S. S. , Li, H. , Cao, C. , Sikoglu, E. M. , Denninger, A. R. , Su, Q. , … Gao, G. (2013). A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice. Molecular Therapy, 21(12), 2136–2147. 10.1038/mt.2013.138 - DOI - PMC - PubMed
    1. Alexander, S. P. H. , Fabbro, D. , Kelly, E. , Marrion, N. V. , Peters, J. A. , Faccenda, E. , … CGTP Collaborators . (2017a). The Concise Guide to PHARMACOLOGY 2017/18: Enzymes. British Journal of Pharmacology, 174, S272–S359. 10.1111/bph.13877 - DOI - PMC - PubMed
    1. Alexander, S. P. H. , Fabbro, D. , Kelly, E. , Marrion, N. V. , Peters, J. A. , Faccenda, E. , … CGTP Collaborators . (2017b). The Concise Guide to PHARMACOLOGY 2017/18: Catalytic receptors. British Journal of Pharmacology, 174, S225–S271. 10.1111/bph.13876 - DOI - PMC - PubMed
    1. Alexander, S. P. H. , Peters, J. A. , Kelly, E. , Marrion, N. V. , Faccenda, E. , Harding, S. D. , … CGTP Collaborators . (2017). The Concise Guide to PHARMACOLOGY 2017/18: Ligand‐gated ion channels. British Journal of Pharmacology, 174, S130–S159. 10.1111/bph.13879 - DOI - PMC - PubMed
    1. Allen, B. , Ingram, E. , Takao, M. , Smith, M. J. , Jakes, R. , Virdee, K. , … Goedert, M. (2002). Abundant τ filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S τ protein. The Journal of Neuroscience, 22(21), 9340–9351. - PMC - PubMed

Publication types